Association Between Prepregnancy Cardiovascular Function and Subsequent Preeclampsia or Fetal Growth Restriction

Preeclampsia and fetal growth restriction during pregnancy are associated with increased risk of maternal cardiovascular disease later in life. It is unclear whether this association is causal or driven by similar antecedent risk factors. Clarification requires recruitment before conception which is methodologically difficult with high attrition rates and loss of outcome numbers to nonconception/miscarriage. Few prospective studies have, therefore, been adequately powered to address these questions. We recruited 530 healthy women (mean age: 35.0 years) intending to conceive and assessed cardiac output, cardiac index, stroke volume, total peripheral resistance, mean arterial pressure, and heart rate before pregnancy. Participants were followed to completion of subsequent pregnancy with repeat longitudinal assessments. Of 356 spontaneously conceived pregnancies, 15 (4.2%) were affected by preeclampsia and fetal growth restriction. Women who subsequently developed preeclampsia/fetal growth restriction had lower preconception cardiac output (4.9 versus 5.8 L/min; P=0.002) and cardiac index (2.9 versus 3.3 L/min per meter2; P=0.031) while mean arterial pressure (87.1 versus 82.3 mm Hg; P=0.05) and total peripheral resistance (1396.4 versus 1156.1 dynes sec cm−5; P<0.001) were higher. Longitudinal trajectories for cardiac output and total peripheral resistance were similar between affected and healthy pregnancies, but the former group showed a more exaggerated fall in mean arterial pressure in the first trimester, followed by a steeper rise and a steeper fall to postpartum values. Significant relationships were observed between cardiac output, total peripheral resistance, and mean arterial pressure and gestational epoch. We conclude that in healthy women, an altered prepregnancy hemodynamic phenotype is associated with the subsequent development of preeclampsia/fetal growth restriction.

[1]  B. Thilaganathan Author's reply re: Pre‐eclampsia is primarily a placental disorder: AGAINST: Pre‐eclampsia: the heart matters , 2018, BJOG : an international journal of obstetrics and gynaecology.

[2]  B. Thilaganathan Pre‐eclampsia is primarily a placental disorder , 2017, BJOG : an international journal of obstetrics and gynaecology.

[3]  N. Kametas,et al.  Longitudinal maternal hemodynamics in pregnancies affected by fetal growth restriction , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  W. Henrich,et al.  Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy , 2017, HYPERTENSION.

[5]  José Guilherme Cecatti,et al.  The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight , 2017, PLoS medicine.

[6]  B. Thilaganathan Placental syndromes: getting to the heart of the matter , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  A. Papageorghiou,et al.  Consensus definition of fetal growth restriction: a Delphi procedure , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  M. Hopman,et al.  Aerobic Exercise Training in Formerly Preeclamptic Women: Effects on Venous Reserve , 2015, Hypertension.

[9]  S. Al-Nasiry,et al.  Maternal metabolic syndrome, preeclampsia, and small for gestational age infancy. , 2015, American journal of obstetrics and gynecology.

[10]  C. Lees,et al.  Hypertension in Pregnancy: Natural History and Treatment Options , 2015, Current Hypertension Reports.

[11]  D. Lawlor,et al.  Modelling Childhood Growth Using Fractional Polynomials and Linear Splines , 2014, Annals of Nutrition and Metabolism.

[12]  José Villar,et al.  International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project , 2014, The Lancet.

[13]  Gustavo Saposnik,et al.  Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[14]  L. Magee,et al.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. , 2014, Pregnancy hypertension.

[15]  C. Lees,et al.  A longitudinal study of maternal cardiovascular function from preconception to the postpartum period , 2014, Journal of hypertension.

[16]  C. Redman,et al.  IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. , 2014, Placenta.

[17]  D. Nelson,et al.  Placental pathology suggesting that preeclampsia is more than one disease. , 2014, American journal of obstetrics and gynecology.

[18]  F. Lyall,et al.  Spiral Artery Remodeling and Trophoblast Invasion in Preeclampsia and Fetal Growth Restriction: Relationship to Clinical Outcome , 2013, Hypertension.

[19]  E. Ferrazzi,et al.  Perinatal morbidity and mortality in early‐onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE) , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[20]  C. Lees,et al.  The feasibility of prospectively studying maternal cardiovascular changes from before conception , 2013, Hypertension Research.

[21]  T. Delhaas,et al.  Hypertension After Preeclampsia Is Preceded by Changes in Cardiac Structure and Function , 2013, Hypertension.

[22]  R. Romero,et al.  Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. , 2013, The Journal of clinical investigation.

[23]  A. Golan,et al.  The placental factor in early- and late-onset normotensive fetal growth restriction. , 2013, Placenta.

[24]  F. Malone,et al.  Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. , 2013, American journal of obstetrics and gynecology.

[25]  L. Peeters,et al.  Early Pregnancy Circulatory Adaptation and Recurrent Hypertensive Disease , 2013, Reproductive Sciences.

[26]  K. Nicolaides,et al.  Maternal hemodynamics at 11–13 weeks' gestation and risk of pre‐eclampsia , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[27]  Michael Mitzenmacher,et al.  Detecting Novel Associations in Large Data Sets , 2011, Science.

[28]  G. Sutherland,et al.  Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment , 2011, Hypertension.

[29]  R. Mikolajczyk,et al.  A global reference for fetal-weight and birthweight percentiles , 2011, The Lancet.

[30]  L. Peeters,et al.  Prepregnancy Low-Plasma Volume and Predisposition to Preeclampsia and Fetal Growth Restriction , 2011, Obstetrics and Gynecology.

[31]  J. Abbott,et al.  Postpartum preeclampsia: emergency department presentation and management. , 2011, The Journal of emergency medicine.

[32]  R. Romero,et al.  The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. , 2011, American journal of obstetrics and gynecology.

[33]  Y. Matsuda,et al.  Clinical features of fetal growth restriction complicated later by preeclampsia , 2009, The journal of obstetrics and gynaecology research.

[34]  D. Charnock-Jones,et al.  Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia , 2009, Placenta.

[35]  Andrew H. Shennan,et al.  Accuracy of inflationary versus deflationary oscillometry in pregnancy and preeclampsia: OMRON-MIT versus OMRON-M7 , 2009, Blood pressure monitoring.

[36]  G. Novelli,et al.  Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease , 2008, Hypertension.

[37]  A. Baschat,et al.  Fetal growth restriction. , 2008, Seminars in perinatology.

[38]  D. Roberts,et al.  The placenta in pre-eclampsia and intrauterine growth restriction , 2008, Journal of Clinical Pathology.

[39]  D. Arduini,et al.  Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end‐diastolic flow in the umbilical artery , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[40]  L. Vatten,et al.  Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study , 2007, BMJ : British Medical Journal.

[41]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[42]  J. Stockman Cardiovascular Health After Maternal Placental Syndromes (CHAMPS): Population-Based Retrospective Cohort Study , 2007 .

[43]  M. Egbor,et al.  Maternal medicine: Morphometric placental villous and vascular abnormalities in early‐ and late‐onset pre‐eclampsia with and without fetal growth restriction , 2006, BJOG : an international journal of obstetrics and gynaecology.

[44]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[45]  R. Shear,et al.  Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? , 2005, American journal of obstetrics and gynecology.

[46]  A. Gabrielsen,et al.  Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. , 2002, Clinical science.

[47]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[48]  G. Saade,et al.  Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. , 2000, American journal of obstetrics and gynecology.

[49]  H. Schouten,et al.  Maternal Volume Homeostasis in Early Pregnancy in Relation to Fetal Growth Restriction , 1995, Obstetrics and gynecology.

[50]  J. Gardosi,et al.  Customised antenatal growth charts , 1992, The Lancet.

[51]  F. P. Hadlock,et al.  In utero analysis of fetal growth: a sonographic weight standard. , 1991, Radiology.

[52]  C. Labarrere,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small‐for‐gestational‐age infants , 1987, British journal of obstetrics and gynaecology.

[53]  T. Khong,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .